Results of our stem cell treatments
The results our patients have achieved by taking our stem cell treatment can be found below. When more results for differing diseases become available, they will be added to this page and to their specific pages.
Please keep in mind that almost all diseases we treat are degenerative. This means that when nothing is done, the health condition will almost certainly deteriorate. Achieving a stable situation -a "no change" result- can be a success in and of itself.
Cerebral Palsy
Follow up statistics from 30 cerebral palsy patients completed in March 2009 show that close to 70% experienced improvements after stem cell therapy.
The mean age of the patients was 9.8 years, while the median age was 6.5 years. The oldest treated patient was 44 years of age. There was no apparent correlation between positive outcome and the number of stem cells administered.
The type of improvements reported include: decreased spasticity; better coordination; improved motor function, improved posture stability; better cognition resulting in communication improvements; gaining the ability to sit, stand or even walk unassisted.
Improved speech articulation was observed in 40% of patients. 20% reported a significant decrease or even absence of epileptic seizures following treatment.
Go to complete Cerebral Palsy treatment results, including more graphs.


Spinal Cord Injury
Follow up statistics from 85 spinal cord injury patients completed in March 2009 show that nearly 60% experienced improvements after stem cell therapy.
These improvements were reported by patients with both incomplete and complete injuries in almost equal proportions. There was no apparent correlation between positive outcome and the number of stem cells administered.
Regaining sensation (feeling warm or cold sensations/ touch) was reported by 40% of patients. 25% reported increased muscle strength and improved endurance.
Better bladder and bowel control and/or gaining erections were also reported by more than 10% of the respondents.
Go to complete spinal cord treatment results, including more graphs.

Diabetes mellitus
In the bar chart below you can see the results of an evaluation
of 23 diabetes (type 1 and type 2) patients. The data was
collected one to six months after the treatment. 
- Three out of 23 patients reported no change in use of medication or feeling of well-being after the treatment.
- Ten out of 23 patients reported a reduction of 25% - 50% of use of insulin and/or oral anti-diabetics and a perceived improvement of well-being. Their HbA1c level was the same or had improved (lowered).
- Ten out of 23 patients reported a strong improvement, with a more than 50% reduced use of insulin and/or oral anti-diabetics. No severe hypoglycemia was reported. Some patients reported a closed leg ulcer. Their HbA1c level was the same or had improved (lowered). They reported a big perceived improvement of well-being and an almost complete absence of pain.
- No patients reported a measurable or perceived deterioration of the quality of their life (regarding usage of medication, pain or feeling of well-being).
Multiple Sclerosis
In the bar chart below you can see the results of an evaluation
of 19 multiple sclerosis patients. The data was collected
one to six months after the treatment.
- Seven out of 19 patients reported no change in spasticity, sensation, mobility or feeling of well-being after the treatment.
- Eight out of 19 patients reported an improvement, with reduced spasticity and/or improved sensation and or/ improved mobility and/or a reduction in fatigue.
- Three out of 19 patients reported a strong improvement, with an absence of spasticity and/or a marked improvement of sensation and/or marked improvement in mobility. They also reported improved bladder control and/or better vision and/or a marked reduction of fatigue.
- One patient reported a perceived deterioration of the quality of his life. The treatment could neither stop nor reverse the advance of the MS symptoms.
Parkinson's disease
In the bar graph below you can see the evaluation of 11 of
Parkinson's disease patients. The data was collected one to
six months after the treatment of each patient. 
- One patient reported no change in muscle spasticity, sensation, mobility or feeling of well-being after the treatment.
- Two out of 11 patients reported an overall improvement, with improved mobility (legs, arms) and/or improved strength. Some patients reported a regaining of muscle strength and/or an improvement of balance. There was some improvement of speech and/or a reduction of pain and spasms.
- Eight out of 11 patients reported a strong improvement, with a marked improvement of mobility, speech and significantly reduced pain and spasms.
- No patients reported a perceived deterioration of the quality of their life.
Stroke
In the bar chart below you can see the evaluation of 17 stroke
patients. The data was collected one to six months after the
treatment.
- Three out of 17 patients reported no change in spasticity, sensation, ability to move or feeling of well-being after the treatment.
- Seven out of 17 patients reported an improvement, with reduced spasticity and/or improved sensation and/or improved ability to move (leg, arm).
- Seven out of 17 patients reported a strong improvement, with an absence of spasticity and/or a marked improvement of sensation (temperature, pin prick, smell, vision). They reported a marked improvement in the ability to move their legs or arms, enabling them to walk (either with or without walking aids). They reported an improvement in muscle control (legs, arms) and/or the ability to grasp items with both arms independently.
- No patients reported a measurable or perceived deterioration of the quality of their life.
ALS
In the bar chart below you can see the evaluation of 53
amyotrophic lateral sclerosis patients. The data was collected one
to six months after the treatment.
- 16 out of 53 patients reported no change in spasticity, sensation, mobility or feeling of well-being after the treatment.
- 19 out of 53 patients reported an improvement, with improved mobility (legs, arms) and/or improved breathing and or/ improved strength. Some patients reported a regain of muscles and/or an improvement of balance, sleeping or a reduction of spasms.
- One out of 53 patients reported a strong improvement, with a marked improvement of mobility, breathing, speech and swallowing.
- 17 out of 53 patients reported a perceived deterioration of the quality of their life. A majority of these patients saw a reduction of mobility, strength, speech/swallowing or balance. The treatment could neither stop nor reverse the advance of the ALS symptoms. It is believed that the treatment has not adversely affected the patients.
Request information and receive a brochure to learn more about our stem cell treatment.
